Researchers at the Ohio State University Medical Center have received a $1.9 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to identify the mechanisms responsible for potentially fatal cardiac arrhythmias in humans. Peter Mohler, director of Ohio State’s Dorothy M. Davis Heart and Lung Research Institute, will lead a team of researchers who will focus on understanding how genetic and acquired defects in the pathways responsible for normal function and electrical activity result in instability in the heart. Researchers will study the role of two different pathways in the heart, ankyrins and EHD proteins, both of which seem unusually disrupted in human disease. Additional Ohio State researchers include Thomas Hund, Jerry Curran, Jingdong Li, Faith Kline, Patrick Wright and Sean DeGrande.
Ohio State Receives NHLBI Award for Arrhythmia Research
This entry was posted in Medical Center News, Research/Innovation and tagged ankyrins, cardiac arrhythmia, Dorthy M. Davis Heart and Lung Research Insitute, EHD proteins, genetics, Lung and Blood, National Institutes of Heart, NHLBI, ohio state, ohio state university medical center, Peter Mohler. Bookmark the permalink.